StockMacro
Menu

Oramed Pharmaceuticals

ORMP on XNAS, Oramed Pharmaceuticals Inc.

Measures activity, not value. Not investment advice.

Bought, last 12 months

$0

vs the 12 months before

Sold, last 12 months

$1.2M

vs the 12 months before

Net, last 12 months

-$1.2M

bought minus sold

Sharp changes

1

clustered insider buying

Window
Record type

What usually follows Companies in the top fifth of insider net purchases (90 days, per $1M of company value, in $100s) beat their sector by a median 0.3 points over the next 6 months, against +2.6 points for the bottom fifth. Clear How we measured it

Who traded

Insiders with counted open-market trades, largest total first. Each name opens every trade of that person, at every company
InsiderRolePurchasesSalesLatest trade
Nadav KidronPresident and CEO4$262K2$4.4M16 Mar 2023
Miriam KidronChief Scientific Officer–3$1.3M14 Mar 2023
Xiaopeng LiDirector2$1.1M–2 Aug 2017
Joshua HexterCOO & CBO–2$746K1 Oct 2026
Kevin RakinDirector–2$537K21 Mar 2022
Avraham GabayChief Financial Officer–2$421K1 Oct 2026
Leonard SankDirector3$273K–9 Sep 2019
Michael RabinowitzChief Commercial Officer–1$167K3 Jan 2023
Yadin RozovDirector1$142K–13 Mar 2023
Arie MayerDirector1$20K1$77K3 Apr 2023
Harold JacobDirector–1$55K10 Mar 2016
Aviad FriedmanDirector1$12K–9 Aug 2018
Bought $0 vs sold $1.2M in the 12 months to Oct 2026

Form 4 open-market trades, by trade date.

See the numbers
Month of Oct 2026: bought $0, sold $226K
Month of Jul 2026: bought $0, sold $942K
Month of Apr 2023: bought $20K, sold $0
Month of Mar 2023: bought $396K, sold $201K
Month of Jan 2023: bought $0, sold $167K
Month of May 2022: bought $0, sold $77K
Month of Mar 2022: bought $0, sold $94K
Month of Sep 2021: bought $0, sold $443K
Month of Aug 2021: bought $0, sold $4.4M
Month of Sep 2019: bought $73K, sold $0
Month of Jul 2019: bought $200K, sold $0
Month of Aug 2018: bought $12K, sold $0
Month of Jul 2018: bought $722, sold $365
Month of Aug 2017: bought $762K, sold $762K
Month of Apr 2017: bought $334K, sold $334K

What the numbers say

  • Bought $0 vs sold $1.2M in the 12 months to Oct 2026.
  • Insider net buying over 12 months: -$1.2M, number 384 of 658 Health Care companies with data (median -$372K).
  • 1 sharp change in all loaded history (clustered insider buying).
  • Open-market trades in the last 12 months by who traded: the largest is officers sold, $1.2M (100%).
  • Latest record: Gabay Avraham (Chief Financial Officer) sold 20,000 shares of ORMP ($90,200), public on 2 Oct 2026.
Open-market trades in the last 12 months by who traded: the largest is officers sold, $1.2M (100%)
See the numbers
Officers sold$1.2M (100%)

Every measure from this source

5 years, by the period each figure describes

Open-market buying. $0 in the latest period, -100% on a year earlier.
Open-market selling. $226K in the latest period.
Insiders buying. 0 in the latest period, -100% on a year earlier.
Insiders selling. 2 in the latest period.

Sharp changes

1 in all loaded history, strongest first

Oramed Pharmaceuticals had 3 insiders buy $415K of its shares on the open market within 30 days (4 filings).

Clustered insider buying, became public on 5 Apr 2023

Who bought: Rozov Yadin, Kidron Nadav, Mayer Arie.

See the evidence (4 source records)
Independent buyers
3
Purchase filings (Form 4, code P)
4
Total bought
$415K
Window
6 Mar 2023 to 5 Apr 2023

Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

The records

Newest first, by the day each became public

Showing 1 to 25 of 27.
Became publicTypeRecord
2 Oct 2026Insider open-market saleGabay Avraham (Chief Financial Officer) sold 20,000 shares of ORMP ($90,200)
2 Oct 2026Insider open-market saleHexter Joshua (COO & CBO) sold 30,000 shares of ORMP ($135,330)
3 Jul 2026Insider open-market saleHexter Joshua (COO & CBO) sold 137,000 shares of ORMP ($611,020)
3 Jul 2026Insider open-market saleGabay Avraham (Chief Financial Officer) sold 73,360 shares of ORMP ($330,854)
5 Apr 2023Insider open-market purchaseMayer Arie (director) bought 8,809 shares of ORMP ($19,518)
17 Mar 2023Insider open-market purchaseKIDRON NADAV (President and CEO) bought 26,000 shares of ORMP ($53,040)
16 Mar 2023Insider open-market purchaseKIDRON NADAV (President and CEO) bought 100,000 shares of ORMP ($201,000)
16 Mar 2023Insider open-market purchaseRozov Yadin (director) bought 70,000 shares of ORMP ($141,700)
16 Mar 2023Insider open-market saleKidron Miriam (Chief Scientific Officer) sold 100,000 shares of ORMP ($201,000)
5 Jan 2023Insider open-market saleRabinowitz Michael (Chief Commercial Officer) sold 13,325 shares of ORMP ($167,170)
11 May 2022Insider open-market saleMayer Arie (director) sold 3,000 shares of ORMP ($76,800)
23 Mar 2022Insider open-market saleRAKIN KEVIN (director) sold 10,000 shares of ORMP ($94,100)
8 Dec 2021Insider open-market saleKIDRON NADAV (President and CEO) sold 220,000 shares of ORMP ($4.4M) [amended]
21 Sep 2021Insider open-market saleRAKIN KEVIN (director) sold 21,100 shares of ORMP ($442,889)
12 Aug 2021Insider open-market saleKIDRON NADAV (President and CEO) sold 220,000 shares of ORMP ($4.4M)
12 Sep 2019Insider open-market purchaseSank Leonard (director) bought 25,000 shares of ORMP ($73,000)
19 Jul 2019Insider open-market purchaseSank Leonard (director) bought 54,517 shares of ORMP ($195,833)
16 Jul 2019Insider open-market purchaseSank Leonard (director) bought 1,320 shares of ORMP ($4,250)
14 Aug 2018Insider open-market purchaseFriedman Aviad (director) bought 2,500 shares of ORMP ($12,370)
13 Jul 2018Insider open-market saleKIDRON NADAV (President and CEO) sold 61 shares of ORMP ($365)
13 Jul 2018Insider open-market purchaseKIDRON NADAV (President and CEO) bought 122 shares of ORMP ($722)
4 Aug 2017Insider open-market purchaseLi Xiaopeng (director) bought 89,636 shares of ORMP ($761,906)
4 Aug 2017Insider open-market saleKidron Miriam (Chief Scientific Officer) sold 89,636 shares of ORMP ($761,906)
20 Apr 2017Insider open-market saleKidron Miriam (Chief Scientific Officer) sold 52,814 shares of ORMP ($334,313)
20 Apr 2017Insider open-market purchaseLi Xiaopeng (director) bought 52,814 shares of ORMP ($334,313)